Document is current

Article History

Received: 3 June 2024

Revised: 9 October 2024

Accepted: 15 November 2024

First Online: 21 December 2024

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Varun Chaudhary has received advisory board fees from Alcon, Roche, Bayer, Novartis, Appelis, Boehringer Ingelheim, and grants from Bayer, Novartis, Roche. Florie Mar and Manuel J. Amador are employees of Genentech, Inc., and own stocks/shares with Genentech, Inc./F. Hoffmann-La Roche Ltd. Andrew Chang has received consulting role fees from Novartis, Bayer, Allergan, Roche, Alcon, Apellis, Zeiss, Astellas Pharma, Opthea, and research grants from Roche, Bayer, Novartis. Kara Gibson, Philippe Margaron, and Insaf Saffar are employed by F. Hoffmann-La Roche Ltd and own stocks/shares with F. Hoffmann-La Roche Ltd. Antonia M. Joussen has received consulting role fees from Novartis, Roche, Bayer, Genentech, Inc., AbbVie, Boehringer Ingelheim, and grants from Novartis, Roche, Bayer, Genentech, Inc., AbbVie, Boehringer Ingelheim, Johnson & Johnson. Judy E. Kim has received advisory board fees from AbbVie, Alimera Sciences, Amgen, Apellis, Bausch & Lomb, Clearside Biomedical, Dutch Ophthalmic Research Center, Eyepoint, Genentech/Roche, Neurotech, Notal Vision, Ophthalmic Therapeutics, Regeneron. Junyeop Lee has received consulting role fees from AbbVie/Allergan, AMC sciences, Bayer, Curacle, Novartis, Roche; and grants/research support from Bayer, Novartis. David Wong has received grants/research support from Bayer, Novartis, Roche, and consulting role fees from AbbVie/Allergan, Alcon, Apellis, Bausch Health, Biogen, Boehringer Ingelheim, Bayer, Novartis, Ripple Therapeutics, Roche, Topcon, Zeiss. Charles Wykoff has received consulting fees/honoraria for ongoing services for 4DMT, AbbVie, Adverum, Aerie, AGTC, Alcon, Alimera, Alkeus, Allgenesis, Alnylam, AMC Sciences, Annexon, Apellis, Arrowhead, Ascidian, Aviceda, Bausch + Lomb, Bayer, Biocryst, Bionic Vision, Boehringer Ingelheim, Cholgene, Clearside, Curacle, Emmecell, EyeBiotech, EyePoint, Foresite, Frontera, Genentech, Gyroscope, IACTA, InGel, IVERIC Bio, Janssen, Kato, Kiora, Kodiak, Kriya, Merck, Merit, Nanoscope, Neurotech, NGM, Notal Vision, Novartis, OccuRx, Ocular Therapeutix, Ocuphire, Ocuterra, OliX, ONL, Opthea, Osanni, Oxular, Palatin, Perceive Bio, Perfuse, Ray, RecensMedical, Regeneron, RegenXBio, Resonance, Roche, Sandoz, Sanofi, Santen, SciNeuro, Stealth, Surrozen, Suzhou Raymon, Sylentis, THEA, Therini, TissueGen, Valo, Verana, Visgenx, Zeiss, grants paid to institution for ongoing research support as a Principal Investigator for trials sponsored by 4DMT, Adverum, AffaMed, Alexion, Alimera, Alkahest, Allgenesis, Amgen, Annexin, Annexon, Apellis, Ascidian, Asclepix, Aviceda, Bayer, Boehringer Ingelheim, Chengdu Kanghong, Chengdu Origen, Clearside, Curacle, EyeBiotech, EyePoint, Gemini, Genentech, GlaxoSmithKline, Gyroscope, IONIS, iRENIX, IVERIC bio, Janssen, Kodiak, Kyoto DDD, Kyowa Kirin, Nanoscope, Neurotech, NGM, Novartis, Ocugen, Ocular Therapeutix, Ocuphire, OcuTerra, OliX, Opthea, Outlook Therapeutics, Oxular, Oxurion, Oyster Point, Perceive Bio, Pykus, RecensMedical, Regeneron, RegenXBio, Rezolute, Roche, SamChunDang Pharm, Sandoz, Shanghai Henlius, Skyline, Stealth, UNITY, Valo, Verily, Xbrane, and stock options (not owner) ongoing from private for-profit entities: InGel, ONL, Osanni, Panther, PolyPhotonix, RecensMedical, TissueGen, Visgenx, Vitranu. Srinivas Sadda has received consulting role fees from Roche/Genentech, Apellis, Amgen, AbbVie/Allergan, Alexion, Samsung Bioepis, Biogen, Boehringer Ingelheim, Iveric Bio, Novartis, Bayer, Pfizer, Astellas, Nanoscope, Jannsen, CenterVue, Optos, Heidelberg, Notal Vision, Topcon, Eyepoint, Character, Ocular Therapeutics, Neurotech, and honoraria/speaker fees from Novartis, Roche, Optos, Heidelberg, NIDEK, is a member of data safety monitoring boards for Regeneron, Regenxbio, and received Research Instruments from iCare, Carl Zeiss Meditec, Optos, NIDEK, Topcon, Heidelberg. Dr Srinivas Sadda and Dr Antonia Joussen are co-editors-in-chief of Graefe's Archive for Clinical and Experimental Ophthalmology.